Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC) an open-label, non-randomized, multi...

Markóczy Zsolt, Sárosi Veronika, Kudaba Iveta, Gálffy Gabriella, Turay Ülkü Yilmaz, Demirkazik Ahmet, Purkalne Gunta, Somfay Attila, Pápai-Székely Zsolt, Rásó Erzsébet, Ostoros Gyula
2018

Optimizing treatment for patients with metastatic renal cell carcinoma in the Central and Eastern European region

Vrdoljak Eduard, Ciuleanu Tudor, Kharkevich Galina, Mardiak Jozef, Mego Michal, Padrik Peeter, Petruzelka Lubos, Purkalne Gunta, Shparyk Yaroslav, Skrbinc Breda, Szczylik Cezary, Torday László
2012